Cade Hovater
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cade Hovater has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Edward T. Naureckas
Section of Pulmonary and Critical Care, Department of Medicine, University of Chicago, Chicago, Illinois
2 shared publications - Kelsey Fredkin
Cystic Fibrosis Foundation Bethesda, MD United States
2 shared publications - Sarah E. Hempstead
Cystic Fibrosis Foundation, Bethesda, Maryland, USA
2 shared publications Kasey Raffensperger
Emory School of Medicine, Randall Rollins Bldg, 5th Floor, 1518 Clifton Rd NE, Atlanta, GA 30322, USA
1 shared publicationNoor Elshaar
Emory School of Medicine, Randall Rollins Bldg, 5th Floor, 1518 Clifton Rd NE, Atlanta, GA 30322, USA
1 shared publication
Latest Publications
- 9 January 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 421-422
Pain is a constant in our lives with CF: Please believe us
- 9 January 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 421-422
Pain is a constant in our lives with CF: Please believe us
- Open Access
- 13 July 2020
- Published by JMIR Publications Inc. in Journal of Participatory Medicine
- Vol. 12 (3) , e17875
Patient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience
Patient and family participation in guideline development is neither standardized nor uniformly accepted in the guideline development community, despite the 2011 Institute of Medicine’s Guidelines We Can Trust and the Guideline International Network’s GIN-Public Toolkit recommendations. The Cystic Fibrosis Foundation has included patients and/or family members directly in guideline development since 2004. Over time, various strategies for increasing patient and family member participation have been implemented. Surveys of recent patient/family and clinical guidelines committee members have shown that inclusion of individuals with cystic fibrosis and their family members on guidelines committees has provided insight otherwise invisible to clinicians.
- 13 July 2020
- Published by JMIR Publications Inc. in Journal of Participatory Medicine
- Vol. 12 (3) , e17875
Open AccessPatient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience
Patient and family participation in guideline development is neither standardized nor uniformly accepted in the guideline development community, despite the 2011 Institute of Medicine’s Guidelines We Can Trust and the Guideline International Network’s GIN-Public Toolkit recommendations. The Cystic Fibrosis Foundation has included patients and/or family members directly in guideline development since 2004. Over time, various strategies for increasing patient and family member participation have been implemented. Surveys of recent patient/family and clinical guidelines committee members have shown that inclusion of individuals with cystic fibrosis and their family members on guidelines committees has provided insight otherwise invisible to clinicians.
- Open Access
- 17 January 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Patient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience (Preprint)
UNSTRUCTURED Patient and family participation in guideline development is neither standardized nor uniformly accepted in the guideline development community, despite the 2011 Institute of Medicine’s Guidelines We Can Trust and the Guideline International Network’s GIN-Public Toolkit recommendations. The Cystic Fibrosis Foundation has included patients and/or family members directly in guideline development since 2004. Over time, various strategies for increasing patient and family member participation have been implemented. Surveys of recent patient/family and clinical guidelines committee members have shown that inclusion of individuals with cystic fibrosis and their family members on guidelines committees has provided insight otherwise invisible to clinicians.
- 17 January 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPatient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience (Preprint)
UNSTRUCTURED Patient and family participation in guideline development is neither standardized nor uniformly accepted in the guideline development community, despite the 2011 Institute of Medicine’s Guidelines We Can Trust and the Guideline International Network’s GIN-Public Toolkit recommendations. The Cystic Fibrosis Foundation has included patients and/or family members directly in guideline development since 2004. Over time, various strategies for increasing patient and family member participation have been implemented. Surveys of recent patient/family and clinical guidelines committee members have shown that inclusion of individuals with cystic fibrosis and their family members on guidelines committees has provided insight otherwise invisible to clinicians.